Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal Pain Management in Robotic Hysterectomy
NCT04429022Phase 3Completed
- Sponsor
- University at Buffalo
- Start
- Nov 2020
- Primary completion
- May 2022
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin, celecoxib oral solution, ketorolac, ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University at Buffalo. Started Nov 2020; status: completed.
02
Drugs
gabapentincelecoxib oral solutionketorolacropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04429022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04429022.